{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T23:00:57Z","timestamp":1789340457059,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Egypt. Public. Health. Assoc."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vancomycin-resistant Enterococci (VRE) represent a critical\u00a0medical and public health concerns\u00a0due to their\u00a0association with serious nosocomial infections and a high risk of\u00a0mortality. We aimed to reveal the pooled prevalence\u00a0of VRE and antimicrobial resistance profiles among enterococci clinical isolates in Egypt.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A PubMed, Scopus, Google Scholar, and Web of Science literature search was carried out in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. Only published studies documenting the prevalence of VRE between 2010 and 2022 were included. Using the random effects model and the 95% confidence intervals, the pooled estimate of VRE was calculated by MedCalc Version 20.113. Cochran\u2019s\n                      <jats:italic>Q<\/jats:italic>\n                      and\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      tests were used to evaluate the degree of heterogeneity, and publication bias was examined by visually examining the funnel plot and its associated tests (Begg\u2019s and Egger\u2019s tests).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The pooled prevalence of VRE among enterococci clinical isolates in Egypt was estimated to be 26% (95% CI 16.9 to 36.3).\n                      <jats:italic>E. faecalis<\/jats:italic>\n                      had a greater pooled prevalence than\n                      <jats:italic>E. faecium<\/jats:italic>\n                      , with 61.22% (95% CI 53.65 to 68.53) and 32.47% (95% CI 27 to 38.2), respectively. The VanA gene is more frequent than the VanB gene among VRE, with a pooled prevalence of 63.3% (95% CI 52.1 to 73.7) and 17.95% (95% CI 7.8 to 31), respectively. The pooled resistance rate of linezolid was substantially lower than that of ampicillin and high-level gentamicin (HLG) 5.54% (95% CI 2.33 to 10%), 65.7% (95% CI 50.8 to 79.2%), and 61.1% (95% CI 47.4 to 73.9), respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The prevalence of VRE is alarmingly high in Egypt.\u00a0It is imperative that antimicrobial stewardship activities and infection control programs are strictly adhered to and\u00a0implemented to prevent further escalation of the problem.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42506-023-00133-9","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T19:02:22Z","timestamp":1681153342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Prevalence of Vancomycin-resistant enterococci (VRE) in Egypt (2010\u20132022): a systematic review and meta-analysis"],"prefix":"10.1186","volume":"98","author":[{"given":"Ahmed","family":"Azzam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Elkafas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya Awny","family":"Elkashef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"issue":"18","key":"133_CR1","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1073\/pnas.1503141112","volume":"112","author":"TP Van Boeckel","year":"2015","unstructured":"Van Boeckel TP, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci USA. 2015;112(18):5649\u201354. https:\/\/doi.org\/10.1073\/pnas.1503141112.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"133_CR2","doi-asserted-by":"publisher","first-page":"1901872","DOI":"10.1002\/advs.201901872","volume":"7","author":"YX Ma","year":"2020","unstructured":"Ma YX, Wang CY, Li YY, Li J, Wan QQ, Chen JH, et al. Considerations and caveats in combating ESKAPE pathogens against nosocomial infections. Adv Sci. 2020;7(1):1901872. https:\/\/doi.org\/10.1002\/advs.201901872.","journal-title":"Adv Sci"},{"issue":"7","key":"133_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.apjtb.2015.05.001","volume":"5","author":"HA Khan","year":"2015","unstructured":"Khan HA, Ahmad A, Mehboob R. Nosocomial infections and their control strategies. Asian Pac J Trop Biomed. 2015;5(7):509\u201314. https:\/\/doi.org\/10.1016\/j.apjtb.2015.05.001.","journal-title":"Asian Pac J Trop Biomed"},{"key":"133_CR4","doi-asserted-by":"publisher","unstructured":"Fiore E, Van Tyne D, Gilmore MS. Pathogenicity of enterococci. Microbiol Spectr. 2019;7(4). https:\/\/doi.org\/10.1128\/microbiolspec.gpp3-0053-2018","DOI":"10.1128\/microbiolspec.gpp3-0053-2018"},{"issue":"11","key":"133_CR5","doi-asserted-by":"publisher","first-page":"5607","DOI":"10.1099\/IJSEM.0.004332","volume":"70","author":"AC Parte","year":"2020","unstructured":"Parte AC, Carbasse JS, Meier-Kolthoff JP, Reimer LC, G\u00f6ker M. List of prokaryotic names with standing in nomenclature (LPSN) moves to the DSMZ. Int J Syst Evol Microbiol. 2020;70(11):5607. https:\/\/doi.org\/10.1099\/IJSEM.0.004332.","journal-title":"Int J Syst Evol Microbiol"},{"key":"133_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.mib.2021.10.013","volume":"65","author":"V Cattoir","year":"2022","unstructured":"Cattoir V. The multifaceted lifestyle of enterococci: genetic diversity, ecology and risks for public health. Curr Opin Microbiol. 2022;65:73\u201380. https:\/\/doi.org\/10.1016\/j.mib.2021.10.013.","journal-title":"Curr Opin Microbiol"},{"issue":"2","key":"133_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/J.IJFOODMICRO.2011.08.014","volume":"151","author":"CMAP Franz","year":"2011","unstructured":"Franz CMAP, Huch M, Abriouel H, Holzapfel W, G\u00e1lvez A. Enterococci as probiotics and their implications in food safety. Int J Food Microbiol. 2011;151(2):125\u201340. https:\/\/doi.org\/10.1016\/J.IJFOODMICRO.2011.08.014.","journal-title":"Int J Food Microbiol"},{"issue":"2\u20133","key":"133_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0168-1605(03)00174-0","volume":"88","author":"CMAP Franz","year":"2003","unstructured":"Franz CMAP, Stiles ME, Schleifer KH, Holzapfel WH. Enterococci in foods\u2014a conundrum for food safety. Int J Food Microbiol. 2003;88(2\u20133):105\u201322. https:\/\/doi.org\/10.1016\/S0168-1605(03)00174-0.","journal-title":"Int J Food Microbiol"},{"key":"133_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jgar.2018.01.017","volume":"14","author":"M Ghahremani","year":"2018","unstructured":"Ghahremani M, Jazani NH, Sharifi Y. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran. J Glob Antimicrob Resist. 2018;14:4\u20139. https:\/\/doi.org\/10.1016\/j.jgar.2018.01.017.","journal-title":"J Glob Antimicrob Resist"},{"key":"133_CR10","unstructured":"World Health Organization, Medicines Selection, IP and Affordability. WHO 2021 AWaRe classification. 2021. Available from: https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification; https:\/\/www.who.int\/westernpacific\/publications-detail\/2021-aware-classification%0A. Accessed 21 Oct 2022."},{"issue":"9","key":"133_CR11","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1128\/JB.00259-12\/ASSET\/8F863FD9-B35C-4D11-B3D2-8D8EA0E45FCD\/ASSETS\/GRAPHIC\/ZJB9990914200002.JPEG","volume":"194","author":"MMC Lam","year":"2012","unstructured":"Lam MMC, Seemann T, Bulach DM, Gladman SL, Chen H, Haring V, et al. Comparative analysis of the first complete Enterococcus faecium genome. J Bacteriol. 2012;194(9):2334\u201341. https:\/\/doi.org\/10.1128\/JB.00259-12\/ASSET\/8F863FD9-B35C-4D11-B3D2-8D8EA0E45FCD\/ASSETS\/GRAPHIC\/ZJB9990914200002.JPEG.","journal-title":"J Bacteriol"},{"issue":"47","key":"133_CR12","doi-asserted-by":"publisher","first-page":"19046","DOI":"10.2807\/ESE.13.47.19046-EN\/CITE\/PLAINTEXT","volume":"13","author":"G Werner","year":"2008","unstructured":"Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill. 2008;13(47):19046. https:\/\/doi.org\/10.2807\/ESE.13.47.19046-EN\/CITE\/PLAINTEXT.","journal-title":"Euro Surveill"},{"issue":"5","key":"133_CR13","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1089\/MDR.2017.0147\/ASSET\/IMAGES\/LARGE\/FIGURE1.JPEG","volume":"24","author":"MO Ahmed","year":"2018","unstructured":"Ahmed MO, Baptiste KE. Vancomycin-resistant enterococci: a review of antimicrobial resistance mechanisms and perspectives of human and animal health. Microb Drug Resist. 2018;24(5):590\u2013606. https:\/\/doi.org\/10.1089\/MDR.2017.0147\/ASSET\/IMAGES\/LARGE\/FIGURE1.JPEG.","journal-title":"Microb Drug Resist"},{"issue":"1","key":"133_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1074-5521(96)90079-4","volume":"3","author":"CT Walsh","year":"1996","unstructured":"Walsh CT, Fisher SL, Park IS, Prahalad M, Wu Z. Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story. Chem Biol. 1996;3(1):21\u20138. https:\/\/doi.org\/10.1016\/S1074-5521(96)90079-4.","journal-title":"Chem Biol"},{"issue":"5","key":"133_CR15","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1016\/j.sjbs.2021.02.022","volume":"28","author":"SK George","year":"2021","unstructured":"George SK, Suseela MR, El Safi S, Elnagi EA, Al-Naam YA, Adam AM, et al. Molecular determination of van genes among clinical isolates of enterococci at a hospital setting. Saudi J Biol Sci. 2021;28(5):2895\u20139. https:\/\/doi.org\/10.1016\/j.sjbs.2021.02.022.","journal-title":"Saudi J Biol Sci"},{"issue":"3","key":"133_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/430909\/2\/41-3-327-FIG002.GIF","volume":"41","author":"CA DiazGranados","year":"2005","unstructured":"DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41(3):327\u201333. https:\/\/doi.org\/10.1086\/430909\/2\/41-3-327-FIG002.GIF.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"133_CR17","doi-asserted-by":"publisher","first-page":"E181","DOI":"10.1111\/1469-0691.12132","volume":"19","author":"ALY Cheah","year":"2013","unstructured":"Cheah ALY, Spelman T, Liew D, Peel T, Howden BP, Spelman D, et al. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect. 2013;19(4):E181-9. https:\/\/doi.org\/10.1111\/1469-0691.12132.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"133_CR18","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1128\/AAC.06299-11","volume":"56","author":"K Hayakawa","year":"2012","unstructured":"Hayakawa K, Marchaim D, Martin ET, Tiwari N, Yousuf A, Sunkara B, et al. Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia. Antimicrob Agents Chemother. 2012;56(5):2452. https:\/\/doi.org\/10.1128\/AAC.06299-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"133_CR19","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1086\/519932","volume":"28","author":"G Ghanem","year":"2007","unstructured":"Ghanem G, Hachem R, Jiang Y, Chemaly RF, Raad I. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infect Control Hosp Epidemiol. 2007;28(9):1054\u20139. https:\/\/doi.org\/10.1086\/519932.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"133_CR20","unstructured":"Centers for Disease Control and Prevention (CDC). 2019 antibiotic resistance threats report. 2021. Available from: https:\/\/www.cdc.gov\/drugresistance\/\/biggest-threats.html. Accessed 21 Oct 2022."},{"issue":"7716","key":"133_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/BMJ.B2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339(7716):332\u20136. https:\/\/doi.org\/10.1136\/BMJ.B2535.","journal-title":"BMJ"},{"issue":"1","key":"133_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13071-017-1970-6\/FIGURES\/5","volume":"10","author":"H Ding","year":"2017","unstructured":"Ding H, Gao YM, Deng Y, Lamberton PHL, Lu DB. A systematic review and meta-analysis of the seroprevalence of Toxoplasma gondii in cats in mainland China. Parasit Vectors. 2017;10(1):1\u201312. https:\/\/doi.org\/10.1186\/S13071-017-1970-6\/FIGURES\/5.","journal-title":"Parasit Vectors"},{"key":"133_CR23","unstructured":"Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions: 10.4.3.1 Recommendations on testing for funnel plot asymmetry.\u00a02011. Available from: https:\/\/handbook-5-1.cochrane.org\/chapter_10\/10_4_3_1_recommendations_on_testing_for_funnel_plot_asymmetry.htm. Accessed 21 Oct 2022."},{"issue":"1","key":"133_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.21608\/zjps.2016.38137","volume":"25","author":"F Serry","year":"2016","unstructured":"Serry F, Elmasry E, Heagazy W, Abdel-Karim S. Antibiotic resistance of Enterococcus faecalis and Enterococcus faecium isolated from urinary tract infections in Zagazig University Hospitals. Zagazig J Pharm Sci. 2016;25(1):30\u20138. https:\/\/doi.org\/10.21608\/zjps.2016.38137.","journal-title":"Zagazig J Pharm Sci"},{"key":"133_CR25","doi-asserted-by":"publisher","unstructured":"Hassan R, El-Gilany AH, Abd-Elaal AM, El-Mashad N, Abdelazim D. Antibiotic resistance pattern of bacteria causing hospital acquired infections in the New Mansoura general hospital, Egypt. Arch Community Med 2021;3(1). https:\/\/doi.org\/10.36959\/547\/645","DOI":"10.36959\/547\/645"},{"issue":"44","key":"133_CR26","doi-asserted-by":"publisher","first-page":"7206","DOI":"10.5897\/AJMR12.1144","volume":"6","author":"RA Alaa-Eldin","year":"2012","unstructured":"Alaa-Eldin RA, El-mahdy HS. Molecular characterization of enterococcus strains isolated from cases of neonatal sepsis in neonatal intensive care unit. African J Microbiol Res. 2012;6(44):7206\u201311. https:\/\/doi.org\/10.5897\/AJMR12.1144.","journal-title":"African J Microbiol Res"},{"issue":"4","key":"133_CR27","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.21608\/amj.2020.120651","volume":"49","author":"AMM Alatrouny","year":"2020","unstructured":"Alatrouny AMM, Amin MA, Shabana HS. Prevalence of vancomycin resistant enterococci among patients with nosocomial infections in intensive care unit. Al-Azhar Med J. 2020;49(4):1955\u201364. https:\/\/doi.org\/10.21608\/amj.2020.120651.","journal-title":"Al-Azhar Med J"},{"key":"133_CR28","unstructured":"Hassan A, Fattouh M, El-deen A, Maguid\u200f S. Isolation and characterization of vancomycin-resistant enterococci (Vre) in surgical wards of Sohag University Hospital. Egy J Med Lab Sci. 2012;21(2):101\u201311."},{"key":"133_CR29","doi-asserted-by":"publisher","unstructured":"Hassan RM, Ghaith DM, Ismail DK, Zafer MM. Reduced susceptibility of Enterococcus spp. isolates from Cairo University Hospital to tigecycline: highlight on the influence of proton pump inhibitors. J Glob Antimicrob Resist. 2018;12:68\u201372. https:\/\/doi.org\/10.1016\/j.jgar.2017.12.005.","DOI":"10.1016\/j.jgar.2017.12.005"},{"issue":"2","key":"133_CR30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4103\/1110-2098.126138","volume":"26","author":"L Azza","year":"2013","unstructured":"\u00a0Labib A,\u00a0 Mahmoud A, Al Ragehy N, Zahran W, Elmasry E. Molecular and phenotypic characterization of hospital-associated and community-associated isolates of Enterococcus spp. Menoufia Med J. 2013;26(2):108. https:\/\/doi.org\/10.4103\/1110-2098.126138.","journal-title":"Menoufia Med J"},{"issue":"1","key":"133_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.12816\/0037103","volume":"25","author":"GA El Shenawy","year":"2016","unstructured":"El Shenawy GA, Abdel-Latif RS, Shedeed DS. Detection of VanA, VanB and VanC genes in vancomycin resistant enterococci in Zagazig University Hospitals. Egypt J Med Microbiol. 2016;25(1):141\u20138. https:\/\/doi.org\/10.12816\/0037103.","journal-title":"Egypt J Med Microbiol"},{"issue":"0","key":"133_CR32","doi-asserted-by":"publisher","first-page":"0","DOI":"10.21608\/ejmm.2021.94566.1006","volume":"0","author":"R Kishk","year":"2021","unstructured":"Kishk R, Nemr N, Soliman N, Riad E, Ahmed M, Soliman N. High-level Aminoglycoside and Vancomycin resistance in Enterococcus spp. isolated from hospital acquired Infections,\u00a0Ismailia Egypt. Egypt J Med Microbiol. 2021; 30 (4):113-9. https:\/\/doi.org\/10.21608\/ejmm.2021.94566.1006.","journal-title":"Egypt J Med Microbiol"},{"key":"133_CR33","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.4103\/0255-0857.148836","volume":"33","author":"YA Hashem","year":"2015","unstructured":"Hashem YA, Yassin AS, Amin MA. Molecular characterization of Enterococcus spp. clinical isolates from Cairo, Egypt. Indian J Med Microbiol. 2015;33:S80-86. https:\/\/doi.org\/10.4103\/0255-0857.148836.","journal-title":"Indian J Med Microbiol"},{"issue":"1s","key":"133_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.7537\/marslsj1301s1608","volume":"13","author":"MM Shalaby","year":"2016","unstructured":"Shalaby MM, Kareman AE, Wageih SEN, El-Sharaby RM. Comparative study between molecular and non-molecular methods used for detection of Vancomycin Resistant Enterococci in Tanta University Hospitals. Egypt Life Sci J. 2016;13(1s):71\u20138. https:\/\/doi.org\/10.7537\/marslsj1301s1608.","journal-title":"Egypt Life Sci J"},{"issue":"3","key":"133_CR35","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1590\/S1517-838246320140403","volume":"46","author":"D Moemen","year":"2015","unstructured":"Moemen D, Tawfeek D, Badawy W. Healthcare-associated vancomycin resistant enterococcus faecium infections in the Mansoura university hospitals intensive care units. Egypt Brazilian J Microbiol. 2015;46(3):777\u201383. https:\/\/doi.org\/10.1590\/S1517-838246320140403.","journal-title":"Egypt Brazilian J Microbiol"},{"issue":"3","key":"133_CR36","first-page":"1859","volume":"9","author":"EA El-Masry","year":"2015","unstructured":"El-Masry EA, Awad ET, Yassin MH. Antibiotic resistance, molecular typing, biofilm formation in Enterococcai isolates causing urinary tract infection. J Pure Appl Microbiol. 2015;9(3):1859\u201366.","journal-title":"J Pure Appl Microbiol"},{"key":"133_CR37","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2147\/IDR.S120227","volume":"9","author":"MM Sallam","year":"2016","unstructured":"Sallam MM, Abou-Aisha K, El-Azizi M. A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant gram-positive bacteria. Infect Drug Resist. 2016;9:301\u201311. https:\/\/doi.org\/10.2147\/IDR.S120227.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"133_CR38","doi-asserted-by":"publisher","first-page":"186","DOI":"10.18683\/germs.2018.1145","volume":"8","author":"R El-Mahdy","year":"2018","unstructured":"El-Mahdy R, Mostafa A, El-Kannishy G. High level aminoglycoside resistant enterococci in hospital-acquired urinary tract infections in Mansoura. Egypt Germs. 2018;8(4):186\u201390. https:\/\/doi.org\/10.18683\/germs.2018.1145.","journal-title":"Egypt Germs"},{"key":"133_CR39","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.2147\/IDR.S189341","volume":"12","author":"HS Said","year":"2019","unstructured":"Said HS, Abdelmegeed ES. Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt. Infect Drug Resist. 2019;12:1113\u201325. https:\/\/doi.org\/10.2147\/IDR.S189341.","journal-title":"Infect Drug Resist"},{"issue":"9","key":"133_CR40","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3855\/jidc.10472","volume":"13","author":"RM Khairy","year":"2019","unstructured":"Khairy RM, Mahmoud MS, Esmail MAM, Gamil AN. First detection of vanB phenotype-vanA genotype vancomycin-resistant enterococci in Egypt. J Infect Dev Ctries. 2019;13(9):837\u201342. https:\/\/doi.org\/10.3855\/jidc.10472.","journal-title":"J Infect Dev Ctries"},{"key":"133_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jgar.2020.02.031","volume":"22","author":"SS El-Kazzaz","year":"2020","unstructured":"El-Kazzaz SS, Abou El-Khier NT. Effect of the lantibiotic nisin on inhibitory and bactericidal activities of antibiotics used against vancomycin-resistant enterococci. J Glob Antimicrob Resist. 2020;22:263\u20139. https:\/\/doi.org\/10.1016\/j.jgar.2020.02.031.","journal-title":"J Glob Antimicrob Resist"},{"key":"133_CR42","doi-asserted-by":"publisher","first-page":"117863371988292","DOI":"10.1177\/1178633719882929","volume":"12","author":"MAM Esmail","year":"2019","unstructured":"Esmail MAM, Abdulghany HM, Khairy RM. Prevalence of multidrug-resistant Enterococcus faecalis in hospital-acquired surgical wound infections and bacteremia: concomitant analysis of antimicrobial resistance Genes. Infect Dis Res Treat. 2019;12:117863371988292. https:\/\/doi.org\/10.1177\/1178633719882929.","journal-title":"Infect Dis Res Treat"},{"issue":"1","key":"133_CR43","doi-asserted-by":"publisher","first-page":"018","DOI":"10.29328\/journal.abb.1001018","volume":"4","author":"NH Alzahran","year":"2020","unstructured":"Alzahran NH, Mohamed EA. Evaluation of the antibacterial and anticancer activities of marine Bacillus subtilis ESRAA3010 against different multidrug resistant Enterococci (MDRE) and cancer cell lines. Arch Biotechnol Biomed. 2020;4(1):018\u201327. https:\/\/doi.org\/10.29328\/journal.abb.1001018.","journal-title":"Arch Biotechnol Biomed"},{"key":"133_CR44","doi-asserted-by":"publisher","DOI":"10.21608\/mid.2022.129600.1265","author":"A Gaballah","year":"2022","unstructured":"Gaballah A, Shawky S, Amer A. Microbiological profiles of neonatal sepsis in northern Egypt. Microbes Infect Dis. 2022. https:\/\/doi.org\/10.21608\/mid.2022.129600.1265.","journal-title":"Microbes Infect Dis"},{"issue":"6","key":"133_CR45","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1089\/MDR.2018.0320","volume":"25","author":"BE Aladarose","year":"2019","unstructured":"Aladarose BE, Said HS, Abdelmegeed ES. Incidence of virulence determinants among enterococcal clinical isolates in Egypt and its association with biofilm formation. Microb Drug Resist. 2019;25(6):880\u20139. https:\/\/doi.org\/10.1089\/MDR.2018.0320.","journal-title":"Microb Drug Resist"},{"issue":"2","key":"133_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/1120009X.2016.1182358","volume":"29","author":"MZ Abdelkareem","year":"2017","unstructured":"Abdelkareem MZ, Sayed M, Hassuna NA, Mahmoud MS, Abdelwahab SF. Multi-drug-resistant Enterococcus faecalis among Egyptian patients with urinary tract infection. J Chemother. 2017;29(2):74\u201382. https:\/\/doi.org\/10.1080\/1120009X.2016.1182358.","journal-title":"J Chemother"},{"issue":"1","key":"133_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s42506-020-00065-8","volume":"96","author":"NAE Fahim","year":"2021","unstructured":"Fahim NAE. Prevalence and antimicrobial susceptibility profile of multidrug-resistant bacteria among intensive care units patients at Ain Shams University Hospitals in Egypt\u2014a retrospective study. J Egypt Public Health Assoc. 2021;96(1):7. https:\/\/doi.org\/10.1186\/s42506-020-00065-8.","journal-title":"J Egypt Public Health Assoc"},{"key":"133_CR48","doi-asserted-by":"publisher","unstructured":"Fahmy N, Abdel-Gawad A, Rezk G, Mahmoud E. Characterization of Enterococci isolated from intensive care unit (ICU): distribution of virulence markers, virulence genes and antibiotic resistance pattern. Microbes Infect Dis. 2021;2(4):725\u201335. https:\/\/doi.org\/10.21608\/mid.2021.76391.1158.","DOI":"10.21608\/mid.2021.76391.1158"},{"issue":"9","key":"133_CR49","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s10096-016-2702-0","volume":"35","author":"M Emaneini","year":"2016","unstructured":"Emaneini M, Hosseinkhani F, Jabalameli F, Nasiri MJ, Dadashi M, Pouriran R, Beigverdi R. Prevalence of vancomycin-resistant Enterococcus in Iran: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2016;35(9):1387\u201392. https:\/\/doi.org\/10.1007\/s10096-016-2702-0.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"133_CR50","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/jcpt.13383","volume":"46","author":"S Shrestha","year":"2021","unstructured":"Shrestha S, Kharel S, Homagain S, Aryal R, Mishra SK. Prevalence of vancomycin-resistant enterococci in Asia\u2014A systematic review and meta-analysis. J Clin Pharm Ther. 2021;46(5):1226\u201337. https:\/\/doi.org\/10.1111\/jcpt.13383.","journal-title":"J Clin Pharm Ther"},{"issue":"12","key":"133_CR51","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1128\/jcm.35.12.3258-3263.1997","volume":"35","author":"PC Kohner","year":"1997","unstructured":"Kohner PC, Patel R, Uhl JR, Garin KM, Hopkins MK, Wegener LT, et al. Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin. J Clin Microbiol. 1997;35(12):3258\u201363. https:\/\/doi.org\/10.1128\/jcm.35.12.3258-3263.1997.","journal-title":"J Clin Microbiol"},{"key":"133_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/AHMT.S180489","volume":"9","author":"A Moghimbeigi","year":"2018","unstructured":"Moghimbeigi A, Moghimbeygi M, Dousti M, Kiani F, Sayehmiri F, Sadeghifard N, et al. Prevalence of vancomycin resistance among isolates of enterococci in Iran: a systematic review and meta-analysis. Adolesc Health Med Ther. 2018;9:177. https:\/\/doi.org\/10.2147\/AHMT.S180489.","journal-title":"Adolesc Health Med Ther"},{"issue":"1","key":"133_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12866-019-1539-Y\/TABLES\/1","volume":"19","author":"A Sattari-Maraji","year":"2019","unstructured":"Sattari-Maraji A, Jabalameli F, Node Farahani N, Beigverdi R, Emaneini M. Antimicrobial resistance pattern, virulence determinants and molecular analysis of Enterococcus faecium isolated from children infections in Iran. BMC Microbiol. 2019;19(1):1\u20138. https:\/\/doi.org\/10.1186\/S12866-019-1539-Y\/TABLES\/1.","journal-title":"BMC Microbiol"},{"issue":"5","key":"133_CR54","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/S10096-016-2607-Y","volume":"35","author":"I Gawryszewska","year":"2016","unstructured":"Gawryszewska I, \u017babicka D, Bojarska K, Malinowska K, Hryniewicz W, Sadowy E. Invasive enterococcal infections in Poland: the current epidemiological situation. Eur J Clin Microbiol Infect Dis. 2016;35(5):847\u201356. https:\/\/doi.org\/10.1007\/S10096-016-2607-Y.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"133_CR55","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/J.1469-0691.2006.01631.X","volume":"13","author":"J Top","year":"2007","unstructured":"Top J, Willems R, Blok H, De Regt M, Jalink K, Troelstra A, et al. Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin Microbiol Infect. 2007;13(3):316\u20139. https:\/\/doi.org\/10.1111\/J.1469-0691.2006.01631.X.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"133_CR56","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/JAC\/DKN360","volume":"62","author":"CH Lester","year":"2008","unstructured":"Lester CH, Sandvang D, Olsen SS, Sch\u00f8nheyder HC, Jarl\u00f8v JO, Bangsborg J, et al. Emergence of ampicillin-resistant Enterococcus faecium in Danish hospitals. J Antimicrob Chemother. 2008;62(6):1203\u20136. https:\/\/doi.org\/10.1093\/JAC\/DKN360.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"133_CR57","doi-asserted-by":"publisher","first-page":"dlab185","DOI":"10.1093\/JACAMR\/DLAB185","volume":"3","author":"C Horner","year":"2021","unstructured":"Horner C, Mushtaq S, Allen M, Hope R, Gerver S, Longshaw C, et al. Replacement of Enterococcus faecalis by Enterococcus faecium as the predominant enterococcus in UK bacteraemias. JAC-Antimicrobial Resist. 2021;3(4):dlab185. https:\/\/doi.org\/10.1093\/JACAMR\/DLAB185.","journal-title":"JAC-Antimicrobial Resist"},{"issue":"1","key":"133_CR58","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/S12879-020-05078-4","volume":"20","author":"W Zhou","year":"2020","unstructured":"Zhou W, Zhou H, Sun Y, Gao S, Zhang Y, Cao X, et al. Characterization of clinical enterococci isolates, focusing on the vancomycin-resistant enterococci in a tertiary hospital in China: based on the data from 2013 to 2018. BMC Infect Dis. 2020;20(1):356. https:\/\/doi.org\/10.1186\/S12879-020-05078-4.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"133_CR59","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1097\/J.PBJ.0000000000000125","volume":"6","author":"OQ Orababa","year":"2021","unstructured":"Orababa OQ, Soriwei JD, Akinsuyi SO, Essiet UU, Solesi OM. A systematic review and meta-analysis on the prevalence of vancomycin-resistant enterococci (VRE) among Nigerians. Porto Biomed J. 2021;6(1):e125. https:\/\/doi.org\/10.1097\/J.PBJ.0000000000000125.","journal-title":"Porto Biomed J"},{"issue":"6","key":"133_CR60","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.ijantimicag.2019.02.009","volume":"53","author":"T Lee","year":"2019","unstructured":"Lee T, Pang S, Abraham S, Coombs GW. Molecular characterization and evolution of the first outbreak of vancomycin-resistant Enterococcus faecium in Western Australia. Int J Antimicrob Agents. 2019;53(6):814\u20139. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.02.009.","journal-title":"Int J Antimicrob Agents"},{"key":"133_CR61","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.drup.2018.10.002","volume":"40","author":"JK Bender","year":"2018","unstructured":"Bender JK, Cattoir V, Hegstad K, Sadowy E, Coque TM, Westh H, et al. Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: towards a common nomenclature. Drug Resist Updat. 2018;40:25\u201339. https:\/\/doi.org\/10.1016\/j.drup.2018.10.002.","journal-title":"Drug Resist Updat"},{"issue":"7","key":"133_CR62","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/JAC\/DKY099","volume":"73","author":"RE Mendes","year":"2018","unstructured":"Mendes RE, Deshpande L, Streit JM, Sader HS, Castanheira M, Hogan PA, et al. ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries. J Antimicrob Chemother. 2018;73(7):1880\u20137. https:\/\/doi.org\/10.1093\/JAC\/DKY099.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"133_CR63","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1128\/AAC.02803-15","volume":"60","author":"RK Flamm","year":"2016","unstructured":"Flamm RK, Mendes RE, Hogan PA, Streit JM, Ross JE, Jonesa RN. Linezolid surveillance results for the United States (LEADER Surveillance Program 2014). Antimicrob Agents Chemother. 2016;60(4):2273. https:\/\/doi.org\/10.1128\/AAC.02803-15.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"133_CR64","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/J.1469-0691.2010.03214.X","volume":"16","author":"CA Arias","year":"2010","unstructured":"Arias CA, Contreras GA, Murray BE. Management of multidrug-resistant enterococcalinfections. Clin Microbiol Infect. 2010;16(6):555\u201362. https:\/\/doi.org\/10.1111\/J.1469-0691.2010.03214.X.","journal-title":"Clin Microbiol Infect"},{"key":"133_CR65","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/IDR.S54125","volume":"8","author":"T O\u2019Driscoll","year":"2015","unstructured":"O\u2019Driscoll T, Crank CW. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist. 2015;8:217. https:\/\/doi.org\/10.2147\/IDR.S54125.","journal-title":"Infect Drug Resist"},{"issue":"8","key":"133_CR66","doi-asserted-by":"publisher","first-page":"GC07","DOI":"10.7860\/JCDR\/2017\/27260.10474","volume":"11","author":"G Yadav","year":"2017","unstructured":"Yadav G, Thakuria B, Madan M, Agwan V, Pandey A. Linezolid and vancomycin resistant enterococci: a therapeutic problem. J Clin Diagn Res. 2017;11(8):GC07. https:\/\/doi.org\/10.7860\/JCDR\/2017\/27260.10474.","journal-title":"J Clin Diagn Res"},{"issue":"9","key":"133_CR67","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/ANTIBIOTICS9090630","volume":"9","author":"J Hrbacek","year":"2020","unstructured":"Hrbacek J, Cermak P, Zachoval R. Current antibiotic resistance trends of uropathogens in central Europe: survey from a Tertiary Hospital Urology Department 2011\u20132019. Antibiot. 2020;9(9):630. https:\/\/doi.org\/10.3390\/ANTIBIOTICS9090630.","journal-title":"Antibiot"},{"issue":"1","key":"133_CR68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3897\/FOLMED.63.E53506","volume":"63","author":"MSS Abadi","year":"2021","unstructured":"Abadi MSS, Taji A, Salehi F, Kazemian H, Heidari H. High-level gentamicin resistance among clinical isolates of enterococci in Iran: a systematic review and meta-analysis. Folia Med (Plovdiv). 2021;63(1):15\u201323. https:\/\/doi.org\/10.3897\/FOLMED.63.E53506.","journal-title":"Folia Med (Plovdiv)"},{"key":"133_CR69","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4103\/IJPVM.IJPVM_320_18","volume":"11","author":"SA Refeai","year":"2020","unstructured":"Refeai SA, Kamal NN, Ghazawy ERA, Fekry CM. Perception and barriers regarding infection control measures among healthcare workers in Minia City. Egypt Int J Prev Med. 2020;11:11. https:\/\/doi.org\/10.4103\/IJPVM.IJPVM_320_18.","journal-title":"Egypt. Int J Prev Med"},{"key":"133_CR70","unstructured":"Greeb HEE, Ahmed AI, Atia HM, Mouty SMA. Assessment of nurses\u2019 compliance with infection control standard precautions at outpatient clinics of urology and nephrology center - Mansoura University. J Nurs Heal Sci. 2018;7(3):54\u20139.\u00a0http:\/\/www.iosrjournals.org\/iosr-jnhs\/papers\/vol7-issue3\/Version-1\/G0703015459.pdf.\u00a0Accessed 21 Oct 2022."},{"issue":"9","key":"133_CR71","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1016\/J.AJIC.2017.03.013","volume":"45","author":"MR Salem","year":"2017","unstructured":"Salem MR, Youssef MRL. Health care providers\u2019 perspectives for providing quality infection control measures at the neonatal intensive care unit, Cairo University Hospital. Am J Infect Control. 2017;45(9):e99-102. https:\/\/doi.org\/10.1016\/J.AJIC.2017.03.013.","journal-title":"Am J Infect Control"},{"issue":"4","key":"133_CR72","doi-asserted-by":"publisher","first-page":"840","DOI":"10.4103\/1110-2098.149804","volume":"27","author":"MESA Salam","year":"2014","unstructured":"Salam MESA, El-Shazly HMA, Dewidar MAAS. Infection control awareness among healthcare providers in family health settings in Shebin El-kom district, Menoufia Governorate. Egypt Menoufia Med J. 2014;27(4):840. https:\/\/doi.org\/10.4103\/1110-2098.149804.","journal-title":"Egypt Menoufia Med J"},{"key":"133_CR73","doi-asserted-by":"publisher","unstructured":"Hendy A, Al-Sharkawi S, Hassanein SMA, Soliman SM. Effect of educational intervention on nurses\u2019 perception and practice of antimicrobial stewardship programs. Am J Infect Control. https:\/\/doi.org\/10.1016\/J.AJIC.2022.05.001.","DOI":"10.1016\/J.AJIC.2022.05.001"},{"issue":"6","key":"133_CR74","doi-asserted-by":"publisher","first-page":"e14081","DOI":"10.1111\/IJCP.14081","volume":"75","author":"AA Elsayed","year":"2021","unstructured":"Elsayed AA, Darwish SF, Zewail MB, Mohammed M, Saeed H, Rabea H. Antibiotic misuse and compliance with infection control measures during COVID-19 pandemic in community pharmacies in Egypt. Int J Clin Pract. 2021;75(6):e14081. https:\/\/doi.org\/10.1111\/IJCP.14081.","journal-title":"Int J Clin Pract"},{"issue":"1","key":"133_CR75","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/S12903-021-01685-Y\/TABLES\/7","volume":"21","author":"MM Aly","year":"2021","unstructured":"Aly MM, Elchaghaby MA. The prescription pattern and awareness about antibiotic prophylaxis and resistance among a group of Egyptian pediatric and general dentists: a cross sectional study. BMC Oral Health. 2021;21(1):322. https:\/\/doi.org\/10.1186\/S12903-021-01685-Y\/TABLES\/7.","journal-title":"BMC Oral Health"},{"issue":"6","key":"133_CR76","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/EJHPHARM-2016-001032","volume":"24","author":"RM El-Hawy","year":"2017","unstructured":"El-Hawy RM, Ashmawy MI, Kamal MM, Khamis HA, Abo El-Hamed NM, Eladely GI, et al. Studying the knowledge, attitude and practice of antibiotic misuse among Alexandria population. Eur J Hosp Pharm. 2017;24(6):349\u201354. https:\/\/doi.org\/10.1136\/EJHPHARM-2016-001032.","journal-title":"Eur J Hosp Pharm"}],"container-title":["Journal of the Egyptian Public Health Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42506-023-00133-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42506-023-00133-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42506-023-00133-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T19:07:35Z","timestamp":1681153655000},"score":1,"resource":{"primary":{"URL":"https:\/\/jepha.springeropen.com\/articles\/10.1186\/s42506-023-00133-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["133"],"URL":"https:\/\/doi.org\/10.1186\/s42506-023-00133-9","relation":{},"ISSN":["2090-262X"],"issn-type":[{"value":"2090-262X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"assertion":[{"value":"25 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}